ArticleBMC cardiovascular disorders2025
The predictive value of AGEF score for contrast-induced nephropathy in patients with lower extremity peripheral artery disease.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLower extremity peripheral artery disease (LEAD) is a disease that impairs quality of life, causes amputation and is associated with mortality. Percutaneous interventions are performed for therapeutic purposes in patients with LEAD. Contrast-induced nephropathy (CIN) may emerge due to the contrast media used during these interventions. This study aimed to investigate the predictive value of six scoring systems, including AGEF, ACEF, Zhi-Feng Yao, CR4EATME3AD3, Mehran, and Tziakas, for CIN.
methodsThis retrospective study included 690 patients with LEAD. The study population was divided into two groups according to the presence of CIN.
resultsIn our study, the AGEF, ACEF, Tziakas, Zhi-Feng Yao, CR4EATME3AD3, and Mehran scoring systems demonstrated robust predictive capabilities for the development of CIN following percutaneous intervention in patients with LEAD. Moreover, the AGEF, Zhi-Feng Yao, CR4EATME3AD3, and Mehran scores were identified as independent predictors of CIN development in patients with LEAD revascularized via endovascular interventions.
conclusionThe findings of this study revealed that various scoring systems performed well in predicting CIN in LEAD patients. In addition, among these scoring systems, AGEF has been shown to be the best in terms of predictive power.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.